Sung-Nam Lim

640 total citations
31 papers, 455 citations indexed

About

Sung-Nam Lim is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Sung-Nam Lim has authored 31 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Sung-Nam Lim's work include Acute Myeloid Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and Cancer Diagnosis and Treatment (4 papers). Sung-Nam Lim is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and Cancer Diagnosis and Treatment (4 papers). Sung-Nam Lim collaborates with scholars based in South Korea, United States and Puerto Rico. Sung-Nam Lim's co-authors include Ki Hyeong Lee, Hye‐Suk Han, Seung Taik Kim, Ok-Jun Lee, Jin An, Kang Hyeon Choe, Ki Man Lee, Dae‐Young Kim, Song‐Yi Choi and Je‐Hwan Lee and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

Sung-Nam Lim

28 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sung-Nam Lim South Korea 12 183 152 140 120 119 31 455
Hiroaki Shimizu Japan 13 105 0.6× 137 0.9× 100 0.7× 46 0.4× 147 1.2× 47 511
Mauro Turrini Italy 12 135 0.7× 64 0.4× 131 0.9× 44 0.4× 160 1.3× 26 400
Cumhur Gökhan Ekmekçi Türkiye 11 199 1.1× 115 0.8× 36 0.3× 39 0.3× 54 0.5× 27 429
Katerina Sfiridaki Greece 11 107 0.6× 146 1.0× 94 0.7× 24 0.2× 90 0.8× 17 376
Emmanouil Spanoudakis Greece 13 125 0.7× 148 1.0× 129 0.9× 19 0.2× 166 1.4× 49 599
Lianfang Pu China 8 59 0.3× 60 0.4× 192 1.4× 50 0.4× 36 0.3× 21 324
Nurdan Taçyıldız Türkiye 11 93 0.5× 115 0.8× 142 1.0× 37 0.3× 20 0.2× 42 492
John Wheeldon United Kingdom 8 71 0.4× 98 0.6× 112 0.8× 40 0.3× 80 0.7× 10 346
Baptiste Lamarthée France 14 109 0.6× 39 0.3× 65 0.5× 46 0.4× 107 0.9× 33 577
Yasufumi Matsuda Japan 10 93 0.5× 60 0.4× 70 0.5× 21 0.2× 65 0.5× 27 259

Countries citing papers authored by Sung-Nam Lim

Since Specialization
Citations

This map shows the geographic impact of Sung-Nam Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sung-Nam Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sung-Nam Lim more than expected).

Fields of papers citing papers by Sung-Nam Lim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sung-Nam Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sung-Nam Lim. The network helps show where Sung-Nam Lim may publish in the future.

Co-authorship network of co-authors of Sung-Nam Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Sung-Nam Lim. A scholar is included among the top collaborators of Sung-Nam Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sung-Nam Lim. Sung-Nam Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Seok Jin, Jing Quan Lim, Sang Eun Yoon, et al.. (2025). Efficacy of combined CD38 and PD-1 inhibition with isatuximab and cemiplimab for relapsed/refractory NK/T-cell lymphoma. Blood. 146(2). 155–166.
2.
Koh, Young‐Il, Ja Min Byun, Junshik Hong, et al.. (2024). Glofitamab combined with poseltinib and lenalidomide for relapsed/refractory diffuse large B cell lymphoma: Interim analysis of GPL study.. Journal of Clinical Oncology. 42(16_suppl). 7066–7066. 2 indexed citations
3.
Lim, Sung-Nam, Ho Jung An, Kyae Hyung Kim, et al.. (2023). MA13.04 Final Overall Survival Analysis of Osimertinib for Patients with NSCLC Harboring Uncommon EGFR Mutations (KCSG-LU15-09). Journal of Thoracic Oncology. 18(11). S145–S145. 3 indexed citations
4.
Chung, Joo Seop, et al.. (2021). Clinical Impact of Extranodal Metabolic Tumor Volume in 240 Diffuse Large B cell Lymphoma Patients with Extranodal Involvement. Annals of Hematology. 100(5). 1221–1229. 1 indexed citations
5.
Chung, Joo Seop, et al.. (2016). Usefulness of spleen volume measured by computed tomography for predicting clinical outcome in primary myelofibrosis. International Journal of Hematology. 104(4). 476–484. 9 indexed citations
6.
Lim, Sung-Nam, et al.. (2014). The Evaluation of the Off-Label Use of Anticancer Drugs in Korea. Annals of Oncology. 25. iv487–iv487. 1 indexed citations
7.
Shin, Yoon Mi, Jieun Yun, Ok-Jun Lee, et al.. (2014). Diagnostic Value of Circulating Extracellular miR-134, miR-185, and miR-22 Levels in Lung Adenocarcinoma-Associated Malignant Pleural Effusion. Cancer Research and Treatment. 46(2). 178–185. 36 indexed citations
8.
9.
Lee, Ok-Jun, Seok Joong Yun, Wun‐Jae Kim, et al.. (2013). Locally recurrent penile apocrine carcinoma initially diagnosed as metastatic adenocarcinoma of colon.. PubMed. 25(6). 777–80. 1 indexed citations
10.
Han, Hye‐Suk, Sung-Nam Lim, Sang Yeub Lee, et al.. (2013). Multiple Cardiac Metastases from a Nonfunctioning Pancreatic Neuroendocrine Tumor. Cancer Research and Treatment. 45(2). 150–154. 7 indexed citations
11.
Lim, Sung-Nam, et al.. (2013). Allogeneic hematopoietic cell transplantation in adult patients with myelodysplastic/myeloproliferative neoplasms. Blood Research. 48(3). 178–178. 19 indexed citations
12.
Lee, Joo Young, Hye‐Suk Han, Sung-Nam Lim, et al.. (2012). Pneumatosis intestinalis and portal venous gas secondary to Gefitinib therapy for lung adenocarcinoma. BMC Cancer. 12(1). 87–87. 20 indexed citations
13.
Lee, Hee Seung, Sung-Nam Lim, Hyun‐Jung Jeon, et al.. (2012). Poorly Differentiated Neuroendocrine Carcinoma in a Perigastric Lymph Node from an Unknown Primary Site. Cancer Research and Treatment. 44(4). 271–274. 5 indexed citations
14.
Choi, Jae Hyun, Hye‐Suk Han, Ok-Jun Lee, et al.. (2011). Positive Response to Trastuzumab in a Case of HER2-Overexpressing Metastatic Gastric Cancer that Presented as Severe Thrombocytopenia. Onkologie. 34(11). 621–624. 4 indexed citations
15.
Han, Hye‐Suk, Jeong Eun Kim, Hyun‐Jung Jeon, et al.. (2011). A pilot study of adrenal suppression after dexamethasone therapy as an antiemetic in cancer patients. Supportive Care in Cancer. 20(7). 1565–1572. 15 indexed citations
16.
Han, Hye‐Suk, Sung-Nam Lim, Jin An, et al.. (2011). Detection of EGFR Mutation Status in Lung Adenocarcinoma Specimens with Different Proportions of Tumor Cells Using Two Methods of Differential Sensitivity. Journal of Thoracic Oncology. 7(2). 355–364. 71 indexed citations
17.
Kim, Sung-Doo, Je‐Hwan Lee, Jung‐Hee Lee, et al.. (2011). Influence of GST Gene Polymorphisms on the Clearance of Intravenous Busulfan in Adult Patients Undergoing Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 17(8). 1222–1230. 48 indexed citations
18.
Choi, Yunsuk, Je‐Hwan Lee, Sung-Doo Kim, et al.. (2011). Single nucleotide polymorphism of Wilms’ tumor 1 gene rs16754 in Korean patients with cytogenetically normal acute myeloid leukemia. Annals of Hematology. 91(5). 671–677. 15 indexed citations
19.
Lee, Je‐Hwan, Kyoo‐Hyung Lee, Jung‐Hee Lee, et al.. (2010). Decreased incidence of febrile episodes with antibiotic prophylaxis in the treatment of decitabine for myelodysplastic syndrome. Leukemia Research. 35(4). 499–503. 25 indexed citations
20.
Kim, Dae‐Young, Je‐Hwan Lee, Jung‐Hee Lee, et al.. (2010). Significance of fibrinogen, D-dimer, and LDH levels in predicting the risk of bleeding in patients with acute promyelocytic leukemia. Leukemia Research. 35(2). 152–158. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroaki Shimizu Breakdown of academic impact, for papers by Mauro Turrini Breakdown of academic impact, for papers by Cumhur Gökhan Ekmekçi Breakdown of academic impact, for papers by Katerina Sfiridaki Breakdown of academic impact, for papers by Emmanouil Spanoudakis Breakdown of academic impact, for papers by Lianfang Pu Breakdown of academic impact, for papers by Nurdan Taçyıldız Breakdown of academic impact, for papers by John Wheeldon Breakdown of academic impact, for papers by Baptiste Lamarthée Breakdown of academic impact, for papers by Yasufumi Matsuda
Rankless by CCL
2026